George founded Cell One Partners in 2018 and began operations in 2019. Previously George cofounded Progenitor Cell Therapy (later known as PCT, and presently as Minaris Regenerative Medicine) in 1998, one of the earliest cell and gene therapy contract development and manufacturing organizations. As chief financial and business officer and later chief development officer, he was instrumental in expanding PCT into a global leader, with facilities today in the U.S., and in Europe and Japan. PCT was sold to Hitachi, Ltd. for $100+ million. During his tenure at PCT, George also oversaw the construction and development of a cell and gene therapy facility in Beijing. Earlier he was president and chief executive officer of Goldberger & Associates, Inc., a global management consulting firm with offices in New York, Bucharest and Kiev. His firm advised U.S. and European companies on developing private and public sector businesses in Hungary, Romania, the Czech Republic, Slovakia, Slovenia, Ukraine, Moldova, Armenia and Georgia. 

 

Previously, George was assistant to the chairman of W. R. Grace & Co., with responsibilities in the U.S. and Asia. He also served on the Grace Commission as project director, working with the CEOs of 160+ leading companies in a survey of federal government operations, identifying cost savings of $424 billion through application of private sector management practices, and assembled and presented the Commission’s final report to President Reagan and to the U.S. cabinet. He started his business career as management consultant for Booz, Allen & Hamilton, now a unit of PricewaterhouseCoopers LLP. George holds an MBA in finance and international business from the Wharton School of Business of the University of Pennsylvania and a BS in systems engineering from the New York University Tandon School of Engineering.